Financial Incentives and Recruitment to the APT Webstudy

NCT06033066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44844

Last updated 2025-06-25

No results posted yet for this study

Summary

This single-blind, three-arm, randomized, controlled trial will assess the impact of messages and financial incentives on the enrollment of demographically diverse individuals to the Alzheimer Prevention Trials (APT) Webstudy. The APT Webstudy is a novel, online registry that employs quarterly cognitive testing using validated platforms. The APT Webstudy implements fully remote assessments, coordinated by the Alzheimer's Therapeutic Research Institute (ATRI) under USC IRB #HS-17-00746. The purpose of the current study is to test whether we can increase enrollment of diverse individuals into the registry. To do this, we will work with Contra Costa Regional Medical Center (CCRMC), the county public hospital and its affiliated health centers in Contra Costa County, California, to test whether sending messages with and without financial incentives to patients who receive primary care with the health system can increase enrollment to the APT Webstudy. The investigators hypothesize that 1) a certain small financial incentive and an award opportunity based incentive (or a drawing with a prize) will increase enrollment rates of CCHS members into the APT Webstudy relative to the control group. The investigators further hypothesize that the award opportunity incentive will increase the enrollment rate of CCRMC patients into the APT Webstudy more than a certain financial incentive with the same expected value.

Conditions

  • Alzheimer Disease
  • Dementia
  • Preclinical Alzheimer's Disease
  • Prodromal Alzheimer's Disease

Interventions

BEHAVIORAL

Financial Incentives

Small financial incentive or prize incentive

BEHAVIORAL

Message

Message inviting participant to enroll

Sponsors & Collaborators

  • American Heart Association

    collaborator OTHER
  • Schaeffer Center for Health Policy & Economics

    collaborator UNKNOWN
  • Alzheimer's Therapeutic Research Institute

    collaborator OTHER
  • University of Southern California

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06033066 on ClinicalTrials.gov